[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:classic-follicular-lymphoma":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Classic Follicular Lymphoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07731789","Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma",[11],"Phase 2","NOT_YET_RECRUITING","2026-08-03T01:02:43.946935Z","2026-07-30T01:46:14.455065Z",[],[]]